Nutrien beat analysts’ expectations for third-quarter profit on Wednesday, and said it would initiate a review of strategic alternatives for its phosphate business.
But with more companies entering the biologicals and biostimulant space, Prairie growers are being urged to look past the hype and dig into the data
Deal expected to close before year-end
Low U.S. corn profitability big threat to phosphate demand, analyst says